Fortis Healthcare Ltd. (FORTIS) fundamentals
Fortis Healthcare Ltd. is a listed company in Healthcare Services, part of the Healthcare sector, listed on the NSE as FORTIS (ISIN INE061F01013). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What Fortis Healthcare Ltd. does
Fortis Healthcare Limited is an India-based integrated healthcare service provider. The Company is primarily engaged in the business of healthcare services. Its segment includes the Healthcare business and the Diagnostics business. The healthcare business includes inpatient and outpatient services, sale of medical and nonmedical items and management fees from hospitals. The diagnostic business includes pathology and radiology services. Its specialties include cardiac sciences, cosmetology, dental sciences, dermatology, general surgery, oncology, urology, neurosurgery, radiology, orthopedics, and organ transplant, among others. The healthcare verticals of the Company primarily consist of day care specialty, diagnostics and tertiary and quaternary care. The Company has approximately 28 healthcare facilities, including projects under development, 4500 operational beds and over 400 diagnostics centers. It operates in India, the United Arab Emirates, Nepal, and Sri Lanka.
Valuation and market data
| Last close | ₹734.70 |
|---|---|
| Market capitalisation | ₹56,657 crore |
| Enterprise value | ₹60,011 crore |
| P/E (TTM) | 53.24 |
| Price to book | 5.57 |
| Price to sales (TTM) | 3.47 |
| Book value per share | ₹131.86 |
| Dividend yield | 13.61% |
| Sector | Healthcare |
| Industry | Healthcare Services |
| Listed since | Wed May 09 |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹9,179 crore | ₹1,366 crore | ₹1,064 crore | 13.80 |
| Mar 2025 | ₹7,850 crore | ₹1,007 crore | ₹809 crore | 10.26 |
| Mar 2024 | ₹6,931 crore | ₹858 crore | ₹645 crore | 7.93 |
| Mar 2023 | ₹6,359 crore | ₹814 crore | ₹633 crore | 7.80 |
| Mar 2022 | ₹5,745 crore | ₹988 crore | ₹790 crore | 7.35 |
Figures are as reported (consolidated), in ₹ crore.
Shareholding pattern
As of Sep 2026:
| Promoters | 31.2% |
|---|---|
| Foreign institutions (FII) | 23.2% |
| Mutual funds | 26.9% |
| Other domestic institutions | 7.5% |
| Retail and others | 11.2% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.